Results
2305
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2305 companies
Fuse Medical
Market Cap: US$4.4m
Manufactures and distributes medical devices in the United States.
FZMD
US$0.061
7D
0%
1Y
-25.7%
Mitesco
Market Cap: US$4.4m
Engages in providing cloud computing, application hosting, and other data center related applications.
MITI
US$0.25
7D
-35.2%
1Y
-7.4%
Bounce Mobile Systems
Market Cap: US$4.4m
Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
BNCM
US$0.0073
7D
-1.4%
1Y
n/a
Visionflex Group
Market Cap: AU$6.7m
Together its subsidiaries, engages in the provision of healthcare and corporate online search and appointment booking services in Australia.
VFX
AU$0.002
7D
0%
1Y
-60.0%
Raphael Pharmaceutical
Market Cap: US$4.4m
A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.
RAPH
US$0.22
7D
0%
1Y
-85.6%
AVVAA World Health Care Products
Market Cap: US$4.3m
Provides natural and therapeutic skin care products worldwide.
AVVH
US$0.0033
7D
23.6%
1Y
153.8%
Aoxing Pharmaceutical Company
Market Cap: US$4.3m
A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.
AOXG
US$0.011
7D
50.0%
1Y
185.0%
Nu-Med Plus
Market Cap: US$4.3m
A medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.
NUMD
US$0.052
7D
4.0%
1Y
4.0%
Virax Biolabs Group
Market Cap: US$4.3m
A biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.
VRAX
US$1.02
7D
-5.6%
1Y
13.3%
Indiva
Market Cap: CA$5.9m
Engages in the production, processing, and sale of cannabis and cannabis related products in Canada.
NDVA.H
CA$0.03
7D
0%
1Y
-45.5%
Quest PharmaTech
Market Cap: CA$5.9m
A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.
QPT
CA$0.035
7D
0%
1Y
16.7%
Azitra
Market Cap: US$4.3m
An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.
AZTR
US$0.29
7D
6.2%
1Y
-95.0%
KMA Holding
Market Cap: US$4.2m
Through its subsidiaries, manufactures human and pet home medical test kits and emergency response mobile hospital units in the United States.
MCDA
US$0.0001
7D
0%
1Y
n/a
Mustang Bio
Market Cap: US$4.2m
A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.
MBIO
US$1.25
7D
11.6%
1Y
-88.1%
Alaunos Therapeutics
Market Cap: US$4.2m
A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.
TCRT
US$2.66
7D
-6.3%
1Y
-76.9%
T2 Biosystems
Market Cap: US$4.2m
An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.
TTOO
US$0.16
7D
-3.8%
1Y
-96.8%
Titan Pharmaceuticals
Market Cap: US$4.2m
Does not have significant operations.
TTNP
US$4.37
7D
-6.5%
1Y
-32.0%
Celadon Pharmaceuticals
Market Cap: UK£3.1m
Engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines.
CEL
UK£0.045
7D
-10.0%
1Y
-95.5%
HeartSciences
Market Cap: US$4.2m
A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.
HSCS
US$3.96
7D
21.5%
1Y
-36.1%
Oragenics
Market Cap: US$4.2m
A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.
OGEN
US$0.19
7D
-5.0%
1Y
-91.4%
Dermata Therapeutics
Market Cap: US$4.2m
A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.
DRMA
US$0.74
7D
-5.9%
1Y
-78.0%
Encision
Market Cap: US$4.2m
A medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States.
ECIA
US$0.35
7D
-2.8%
1Y
-30.0%
Verici Dx
Market Cap: UK£3.0m
Develops prognostic and diagnostic tests for kidney transplant patients.
VRCI
UK£0.013
7D
11.1%
1Y
-84.4%
Aclarion
Market Cap: US$4.1m
Operates as a healthcare technology company in the United States.
ACON
US$6.70
7D
-3.5%
1Y
-99.8%
Trellus Health
Market Cap: UK£3.0m
Provides digital chronic condition management solutions for employers and health plans.
TRLS
UK£0.018
7D
0%
1Y
12.1%
XORTX Therapeutics
Market Cap: CA$5.5m
A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.
XRTX
CA$1.31
7D
-9.0%
1Y
-62.6%
Sharps Technology
Market Cap: US$4.0m
A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
STSS
US$4.05
7D
-11.4%
1Y
-99.7%
Nuwellis
Market Cap: US$4.0m
A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
NUWE
US$0.93
7D
-1.4%
1Y
-89.4%
Invion
Market Cap: AU$6.2m
A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.
IVX
AU$0.08
7D
-15.8%
1Y
-84.0%
Zero Candida Technologies
Market Cap: CA$5.5m
A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.
ZCT
CA$0.28
7D
-15.2%
1Y
n/a
Rua Bioscience
Market Cap: NZ$6.7m
Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.03
7D
7.1%
1Y
-57.1%
TrivarX
Market Cap: AU$6.2m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
TRI
AU$0.01
7D
-23.1%
1Y
-66.7%
Mosaic ImmunoEngineering
Market Cap: US$4.0m
A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.
CPMV
US$0.49
7D
-9.3%
1Y
16.3%
MindBio Therapeutics
Market Cap: CA$5.5m
Operates as a clinical stage drug development company in Australasia.
MBIO
CA$0.01
7D
0%
1Y
-80.0%
ATI Physical Therapy
Market Cap: US$4.0m
Operates as an outpatient physical therapy provider that provides outpatient rehabilitation and adjacent healthcare services through its clinics in the United States.
ATIP
US$0.90
7D
0%
1Y
-81.3%
PainReform
Market Cap: US$3.9m
A clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.
PRFX
US$1.97
7D
3.1%
1Y
-88.3%